ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer

Prostate cancer (PCa) is the second most common killer among men in Western countries. Targeting androgen receptor (AR) signaling by androgen deprivation therapy (ADT) is the current therapeutic regime for patients newly diagnosed with metastatic PCa. However, most patients relapse and become resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Fararjeh, AbdulFattah Salah, Liu, Yen-Nien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600524/
https://www.ncbi.nlm.nih.gov/pubmed/31181727
http://dx.doi.org/10.3390/ijms20112802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600524/
https://www.ncbi.nlm.nih.gov/pubmed/31181727
http://dx.doi.org/10.3390/ijms20112802

Ejemplares similares